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Are Obesity Risk Genes Associated with Binge Eating
in Adolescence?
Nadia Micali1, Alison E. Field2,3,4, Janet L. Treasure5, and David M. Evans6,7,8
Objective: Cognitions and behaviors characteristic of binge eating are associated with a polymorphism
in the FTO gene, robustly related to body mass index (BMI) and obesity risk. We investigated the associ-
ation between binge eating and the individual and combined effect of 32 SNPs robustly associated with
BMI in a population-based sample. We hypothesized that higher BMI and binge eating might share a
common genetic etiology.
Methods: Binge eating was assessed in adolescents from the Avon Longitudinal Study of Parents and
Children at age 14 (n5 5,958) and 16 years (n54,948). We tested associations between 32 BMI-related
SNPs and binge eating in crude and BMI-, age-, and gender-adjusted regression models.
Results: Crude analyses showed an association between binge eating and rs1558902 (FTO) that per-
sisted after adjustment for BMI (OR5 1.20, P58 3 1023). A weighted allelic score consisting of all 32
BMI-related SNPs was associated with binge eating (P5 8 3 1024); this association attenuated (P5 0.08)
when rs1558902 was removed from the weighted allelic score.
Conclusions: BMI-related genes are associated with adolescent binge eating, in particular an FTO poly-
morphism. Although replication is needed, our findings have biological plausibility and are consistent with
a postulated effect of FTO on appetite and food intake. Future studies should aim to understand the
mechanisms underlying the relationship between FTO, binge eating, and obesity.
Obesity (2015) 23, 1729–1736. doi:10.1002/oby.21147
Introduction
Binge-eating disorder (BED) is the most common eating disorder
(ED) in the general population, with a lifetime prevalence of about
1.5% in adolescents and adults (1,2), and is associated with adverse
physical and psychological outcomes (3,4). BED is characterized by
episodes of overeating with loss of control (occurring on average
once a week over 3 months) and accompanied by distress. BED has
recently been recognized as a diagnostic category in DSM5 (5). The
prevalence of engaging in binge eating behaviors, both in the con-
text of a full-criteria ED diagnosis or in the absence of other ED
features, is about 10% in adults (6) and adolescents (7). Binge eat-
ing is most common in individuals who are overweight/obese (8).
It is widely accepted that ED are partly explained by genetic factors
(9). However, since BED was only recently recognized as an official
disorder, few studies have investigated genetic risk for BED. Despite
the paucity of research there is initial evidence that genetic factors
influence risk for BED (9). Heritability estimates range between
0.39 (10) in a mixed-gender sample of Norwegian twins and 0.45 in
a female-only twin sample (11). Evidence from twin studies shows a
moderate correlation between obesity and binge eating, which
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suggests that some of the same genetic factors might influence both
obesity and binge eating (12).
Genetic association studies have investigated risk-conferring genes
particularly in the dopamine, serotonin, and appetitive systems. Two
studies found an association between MC4R (melanocortin 4 recep-
tor) variants and BED (13,14), but another study failed to find an
association (15). A more recent study of 289 youth aged between 6
and 19 years found an association between a polymorphism in the
FTO locus and loss-of-control eating, which is one of the main char-
acteristics of BED/binge eating behavior (16). Similarly a recent
study showed an association between a weighted allelic risk score,
obtained from combining the effect of 32 SNPs robustly associated
with body mass index (BMI), and emotional and uncontrolled eating
(17), behaviors highly correlated with binge eating (18).
Based on these studies and evidence from our studies that BED pre-
dicts overweight (3), we aimed to: (1) investigate whether variants
previously identified as associated with BMI (17) were also associ-
ated with adolescent binge eating (overeating with loss of control)
and (2) test the role of a polygenic weighted allelic score [obtained
by combining the 32 independent genetic variants associated with
BMI from a genome-wide association study (19)]. We also aimed to
explore whether associations varied by gender and frequency of
binge eating at each time-point.
Methods
Participants
The Avon Longitudinal Study of Parents and Children (ALSPAC) is
a longitudinal, population-based, prospective study of women and
their children (20). All pregnant women living in the geographical
area of Avon, UK, who were expected to deliver their baby between
1st April 1991 and 31st December 1992 were invited to take part in
the study. All women gave informed and written consent. The study
website contains details of all the data that are available through a
fully searchable data dictionary (http://www.bris.ac.uk/alspac/
researchers/data-access/data-dictionary).
The children from 14,541 pregnancies were enrolled; 13,988
children were alive at 1 year. At age 14 years 10,303 adolescents
(singletons) were eligible for follow-up (20) and were sent
questionnaires; 5,958 adolescents (57.8% of those eligible) returned
completed questionnaires. At age 16 years 9,660 adolescents
(singletons) were sent questionnaires and 4,948 returned them
(51.2%).
Ethical approval for the study was obtained from the ALSPAC
Ethics and Law Committee and the Local Research Ethics
Committees.
Binge eating
Binge eating was assessed using a two-part question (21). Partici-
pants were first asked about the frequency during the past year of
eating a very large amount of food. Those who answered yes were
directed to a follow-up question that asked whether they felt out of
control during these episodes, i.e., whether they could not stop eat-
ing even if they wanted to stop. Adolescents who answered yes to
both questions were classified as engaging in binge eating.
For the purpose of the study we used binge eating either at 14 or 16
years of age as an outcome. We also created an ordinal variable for
frequency of bingeing reported in the year prior to assessment
(never,< once a month, one to three times per month, once a week,
>once a week), in order to determine whether increasing frequency
of binge eating was associated with genetic risk.
Genotyping
In total, 9,912 participants were genotyped using the Illumina
HumanHap550 quad genome-wide SNP genotyping platform by the
Wellcome Trust Sanger Institute, Cambridge, UK, and the Labora-
tory Corporation of America, Burlington, NC. Individuals were
excluded from analyses on the basis of excessive or minimal hetero-
zygosity, gender mismatch, individual missingness (>3%), cryptic
relatedness as measured by identity by descent (genome-wide IBD
>10%) and sample duplication. Individuals were assessed for popu-
lation stratification using multi-dimensional scaling modeling seeded
with HapMap Phase II release 22 reference populations. Individuals
of non-European ancestry were removed from further analyses.
SNPs with a final call rate of <95%, minor allele frequency (MAF)
<1% and evidence of departure from Hardy-Weinberg equilibrium
(HWE) (P< 5 3 1027) were also excluded from analyses (22). Indi-
viduals were imputed to HapMap Phase II (Build 36, release 22)
using the Markov Chain Haplotyping software (MACH v.1.0.16)
(23).
From these genome-wide data the 32 SNPs previously identified in
a large GWAS meta-analysis (19) as being robustly and independ-
ently associated with BMI were selected. We also generated
weighted polygenic allelic scores using these 32 SNPs. The esti-
mated dosage of each effect allele was weighted by its regression
coefficient from Speliotes et al (19). We calculated allelic scores
using all 32 SNPs and using 31 SNPs excluding the FTO variant.
Covariates
BMI, weight (kg)/height (m)2, was obtained from measured weight
and height during a face to face assessment at mean age 13.5 and
mean age 15.5 years. BMI at 13.5 was used as the main covariate, if
this was missing, BMI at mean age 15.5 was used (correlations
between BMI at the two time-points was very high r5 0.98). Data
on BMI were available on 4,048 adolescents (82.3% of those with
available data on binge eating and genotype).
Data on binge eating and genotype were available on 4,360 adoles-
cents (2,406 girls and 1,954 boys) at 14 years, and 3,663 (2,151 girls
and 1,512 boys) at 16 years. Overall 4916 adolescents had genotype
data and information on binge eating at either age 14 or 16 (2725
girls and 2191 boys).
Data analyses
We tested the effect of BMI associated SNPs in unadjusted and
adjusted logistic regression models where binge eating was the out-
come. Adjusted models included age, BMI and gender as covariates.
Unadjusted logistic regression models were also conducted stratify-
ing by gender to investigate whether the pattern of association dif-
fered between males and females. In order to increase the power of
our analyses, we examined the relationship between a weighted
allelic risk score and binge eating at either age in an unadjusted
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logistic regression model. We used effect size coefficients as
reported in Speliotes et al. (19) to weight individual SNPs. In order
to assess the contribution of the FTO variant to the allelic score,
two models were tested, one including all 32 SNPs and one com-
prising 31 SNPs and excluding the FTO variant.
Finally, we investigated the relationship between BMI associated
SNPs and an ordinal indicator of binge eating (frequency-based) in
age stratified adjusted (for gender and BMI) ordinal logistic regres-
sion models.
Analyses were run using STATA 12 and the R software package
2.15.2.
Results
The prevalence of binge eating in adolescence was 5.6% at age 14
years and 11.2% at age 16 years amongst adolescents included in
the study (See Table 1). Binge eating was more common in girls at
both age 14 (7.4% of girls, 3.5% of boys) and 16 (16.1% of girls
and 4.4% of boys).
Relationship between BMI variants and binge
eating at either 14 or 16 years of age
Minimally adjusted analyses (adjusted for gender and age)
revealed an association in the hypothesised direction between the
A allele of rs1558902 (FTO) and increased risk of binge eating
[odds ratio (OR)5 1.25 (95% CI: 1.10-1.41), P5 5.1 3 1024].
This association showed little attenuation after adjusting for BMI
(OR5 1.20 (95% CI: 1.05-1.38), P5 8.0 3 1023) (Table 2).
There was also nominal evidence of a protective association
(direction opposite to that expected) between rs10150332
(NRXN3) and binge eating in unadjusted (OR5 0.85 (95% CI:
0.72-0.99), P5 0.038), but not adjusted analyses [OR5 0.88 (95%
CI: 0.74-1.04), P5 0.13].
Females (OR5 1.30, P5 3.3 3 1024) displayed slightly stronger
evidence for association at the FTO locus than males (OR5 1.23,
P5 0.51), but the difference was not significant (P5 0.26)
(Table 3).
Amongst girls there was nominal association between rs2112347
(FLJ35779/HMGCR) and binge eating in the expected direction
(OR=1.21 (95%CI: 1.04-1.40), P5 0.012) (see Table 3), whilst in
boys there was nominal evidence of association between rs2815752
(NEGR1) and binge eating in the expected direction (OR5 1.32
(95%CI: 1.00-1.73, P5 0.047) and rs10150332 (NRXN3) and binge-
ing in the direction opposite to expected (OR5 0.70 (95%CI: 0.49-
1.01), P5 0.047).
Frequency of binge eating
Ordinal regression models confirmed the association between the A
allele of rs1558902 (FTO) and higher binge eating frequency at age
14 years [OR5 1.21 (95%CI: 1.01-1.46), P5 0.04] and at 16 years
[OR5 1.28 (95% CI: 1.10-1.48), P5 1.0 3 1023]. In other words,
the presence of the A allele increased the odds of higher binge eat-
ing frequency (from never to less than monthly, monthly, weekly,
and more than weekly) by 28% for each increase in level at age 16
(see Table 4).
Two SNPs showed nominal association with frequency of binge eat-
ing at either age 14 [rs3817334 (MTCH2): OR5 1.21 (95%CI: 1.01-
1.46), P5 0.03] or 16 years [rs1514175 (TNNI3K): OR=1.17 (95%
CI: 1.01-1.36), P5 0.04] in the expected direction; but these did not
replicate across ages.
Polygenic risk score
In unadjusted analyses, the weighted polygenic risk score was
strongly positively associated with adolescent binge eating at either
age 14 or 16 (P5 7.9 3 1024). This association weakened dramati-
cally once FTO was removed from the score (P5 0.08). The same
pattern was seen in females with the 32 allelic variant weighted
polygenic risk score being strongly positively associated with binge
eating (P5 8.6 3 1024), but not after FTO was removed from the
risk score (P5 0.08). The risk score was not strongly associated
with binge eating in males (all P> 0.05).
Discussion
This is the first study to investigate the association between binge
eating in adolescence and 32 SNPs that have been robustly associ-
ated with BMI, and to include the effect of a weighted allelic score
of 32 SNPs associated with BMI. We investigated this association
across genders, and explored the association between 32 SNPs and
increasing frequency of binge eating (as a more sensitive measure of
binge eating and a severity indicator).
We found a significant positive (risk-conferring) association between
the A allele of the FTO SNP (rs1558902) and adolescent binge eat-
ing, independent of BMI. This association was also found when
TABLE 1 Characteristics of the sample under study with complete data (genotype and phenotype)
Age 14 (n54,360) Age 16 (n5 3,663)
Cases (n5245)
(5.6%)
Controls
(n5 4,115)
Cases (n5 412)
(11.2%)
Controls
(n5 3,251)
Gender, females N (%) 177 (72.5%) 2,229 (54.2%) 346 (84.0%) 1,805 (55.5%)
Age, mean (SD) 14.05 (0.21) 14.04 (0.19) 16.66 (0.23) 16.68 (0.24)
BMI, mean (SD) 21.7 (3.9) 20.2 (3.33) 22.51 (4.0) 21.21 (3.31)
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investigating binge eating as a frequency-based ordinal outcome
(engaging in binge eating weekly, monthly, or less than monthly).
Analyses stratified by gender showed some evidence for gender dif-
ferences suggesting the FTO rs1558902 A allele might confer
increased risk of binge eating amongst girls compared to boys,
although the absence of an effect on boys might also be due to
lower power due to a reduced prevalence of binge eating in boys (a
formal test for interaction was not significant).
A weighted allelic risk score derived from 32 variants associated
with BMI showed a positive association with binge eating in
unadjusted analyses, with a seemingly stronger effect in girls.
Removing the rs1558902 (FTO) variant from the allelic risk score
attenuated the association between the risk score and binge eating,
suggesting that: (i) the FTO variant is the major variant driving the
association with binge eating, and (ii) the association with bingeing
is unlikely to be mediated by BMI (in which case we would also
expect an allelic score of BMI SNPs to show strong association with
bingeing).
The association between SNPs at the FTO locus and other EDs
[anorexia (AN) and bulimia nervosa (BN)] has been examined in
the literature and resulted in conflicting findings. In particular a
TABLE 2 Association between binge eating in adolescence and genetic variants reliably related to BMI
Chrom Position SNP
Putative
gene
Effect
alleleb
Other
allele RSQR
Minimally adjusteda
model (N54,916)
Conditional on BMI,
age, and sex (N5 4,048)
OR (95% CI)c P value OR (95% CI)c P value
1 72585028 rs2815752 NEGR1 A G 0.996 1.06 (0.93-1.20) 0.39 1.02 (0.89-1.18) 0.77
1 74764232 rs1514175 TNNI3K A G 0.998 1.08 (0.95-1.22) 0.25 1.03 (0.90-1.19) 0.64
1 96717385 rs1555543 PTBP2 C A 0.996 1.02 (0.89-1.16) 0.78 1.01 (0.88-1.17) 0.87
1 176156103 rs543874 SEC16B G A 0.997 1.02 (0.88-1.19) 0.76 0.94 (0.79-1.11) 0.46
2 612827 rs2867125 TMEM18 C T 0.999 1.09 (0.92-1.29) 0.30 1.07 (0.89-1.29) 0.49
2 25011512 rs713586 RBJ/ADCY3/POMC C T 0.999 1.02 (0.90-1.15) 0.77 0.97 (0.85-1.12) 0.69
2 59156381 rs887912 FANCL T C 0.997 0.93 (0.81-1.07) 0.32 0.86 (0.74-1.01) 0.058
2 142676401 rs2890652 LRP1B C T 0.989 1.02 (0.87-1.20) 0.80 0.95 (0.79-1.14) 0.59
3 85966840 rs13078807 CADM2 G A 0.997 0.99 (0.85-1.16) 0.91 0.95 (0.80-1.13) 0.58
3 187317193 rs9816226 ETV5 T A 0.956 1.03 (0.87-1.21) 0.75 0.98 (0.82-1.18) 0.86
4 44877284 rs10938397 GNPDA2 G A 0.988 1.10 (0.97-1.25) 0.13 1.11 (0.97-1.28) 0.14
4 103407732 rs13107325 SLC39A8 T C 0.997 1.05 (0.83-1.33) 0.69 1.01 (0.77-1.33) 0.93
5 75050998 rs2112347 FLJ35779/HMGCR T G 0.995 1.14 (1.00-1.29) 0.055 1.15 (1.00-1.34) 0.051
5 124360002 rs4836133 ZNF608 A C 0.943 1.08 (0.95-1.22) 0.27 1.11 (0.96-1.28) 0.15
6 34410847 rs206936 HMGA1 G A 0.988 1.00 (0.86-1.17) 0.97 1.00 (0.84-1.19) 0.98
6 50911009 rs987237 TFAP2B G A 0.999 1.07 (0.91-1.25) 0.42 1.05 (0.87-1.25) 0.62
9 28404339 rs10968576 LRRN6C G A 0.999 1.02 (0.89-1.16) 0.83 1.01 (0.87-1.17) 0.87
11 8561169 rs4929949 RPL27A C T 0.967 0.96 (0.84-1.09) 0.50 0.98 (0.85-1.13) 0.82
11 27682562 rs10767664 BDNF A T 0.997 1.11 (0.95-1.30) 0.18 1.05 (0.88-1.25) 0.61
11 47607569 rs3817334 MTCH2 T C 0.998 1.02 (0.90-1.15) 0.78 0.96 (0.84-1.11) 0.60
12 48533735 rs7138803 FAIM2 A G 0.998 0.99 (0.87-1.13) 0.93 0.99 (0.86-1.15) 0.92
13 26918180 rs4771122 MTIF3 G A 0.931 0.94 (0.81-1.09) 0.41 0.95 (0.80-1.12) 0.54
14 29584863 rs11847697 PRKD1 T C 0.969 0.88 (0.64-1.21) 0.41 0.83 (0.59-1.19) 0.30
14 79006717 rs10150332 NRXN3 C T 0.996 0.85 (0.72-0.99) 0.038 0.88 (0.74-1.04) 0.13
15 65873892 rs2241423 MAP2K5 G A 0.999 1.00 (0.86-1.16) 0.99 0.97 (0.83-1.15) 0.75
16 19841101 rs12444979 GPRC5B C T 0.998 1.13 (0.94-1.36) 0.20 1.06 (0.87-1.31) 0.55
16 28793160 rs7359397 SH2B1 T C 0.999 0.97 (0.85-1.09) 0.59 0.94 (0.82-1.09) 0.42
16 52361075 rs1558902 FTO A T 0.997 1.25 (1.10--1.41) 5.1 3 1024 1.20 (1.05-1.38) 8.0 3 1023
18 55990749 rs571312 MC4R A C 0.999 1.09 (0.94-1.25) 0.27 0.99 (0.84-1.16) 0.89
19 39001372 rs29941 KCTD15 G A 0.999 0.97 (0.85-1.10) 0.61 0.98 (0.85-1.14) 0.81
19 50894012 rs2287019 QPCTL/GIPR C T 0.999 0.99 (0.85-1.16) 0.90 0.93 (0.78-1.10) 0.39
19 52260843 rs3810291 TMEM160 A G 0.765 1.03 (0.89-1.20) 0.68 0.94 (0.80-1.11) 0.49
aAdjusted for sex.
bBMI increaser allele.
cOne tailed binomial sign test indicated that the direction of allelic association with binge eating did not occur significantly more often in the same direction as the known
BMI associations (minimally adjusted model P5 0.11; conditional model P5 0.69).
Bold font indicates statistically significant results (P 0.05).
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recent study found an association between the obesity predisposing
allele of the FTO variant rs9939609 and AN (24) but not with BN
(once adjusted for BMI). In contrast an earlier study did not find an
association between the same SNP and AN in a smaller sample of
225 patients with AN and 1,351 controls (25).
The rs1558902 polymorphism is in high linkage disequilibrium with
the rs9939609 FTO SNP (r25 0.93 in CEU HapMap 2) and a recent
meta-analysis has shown similarly strong associations between each
of these SNPs and overweight/obesity in children and adolescents
(26). There is reason to believe that FTO locus SNPs may be related
to binge eating. Both rs1558902 and rs9939609 have previously
been associated with eating behavior, such as loss of control in ado-
lescents (16), food choice and higher intake of energy-dense food in
children (27,28), food responsiveness (29), and decreased satiety
(30). A recent study also showed a positive association between
rs1558902 (FTO) and the cognitive restraint subscale from the three
factor eating questionnaire (a measure of restrained eating) (17).
Taken together these findings suggest that polymorphisms at the
FTO locus might increase the risk for both binge eating and
TABLE 3 Association between binge eating in adolescence and genetic variants reliably related to BMI stratified according to
sex
Chrom Position SNP Putative gene
Effect
allelea
Other
allele RSQR
Females, minimally
adjusted model
(N5 2,725)
Males, minimally
adjusted model
(N52,191)
OR (95% CI)b P value OR (95% CI)b P value
1 72585028 rs2815752 NEGR1 A G 0.996 0.99 (0.86-1.15) 0.92 1.32 (1.00-1.73) 0.047
1 74764232 rs1514175 TNNI3K A G 0.998 1.09 (0.94-1.26) 0.24 1.03 (0.79-1.33) 0.83
1 96717385 rs1555543 PTBP2 C A 0.996 0.99 (0.86-1.14) 0.85 1.14 (0.87-1.49) 0.35
1 176156103 rs543874 SEC16B G A 0.997 0.96 (0.80-1.14) 0.60 1.27 (0.95-1.71) 0.12
2 612827 rs2867125 TMEM18 C T 0.999 1.10 (0.91-1.34) 0.32 1.06 (0.74-1.51) 0.75
2 25011512 rs713586 RBJ/ADCY3/POMC C T 0.999 1.02 (0.89-1.18) 0.75 1.00 (0.77-1.30) 0.98
2 59156381 rs887912 FANCL T C 0.997 0.96 (0.81-1.12) 0.57 0.86 (0.64-1.15) 0.31
2 142676401 rs2890652 LRP1B C T 0.989 1.06 (0.88-1.28) 0.53 0.89 (0.63-1.27) 0.52
3 85966840 rs13078807 CADM2 G A 0.997 0.96 (0.81-1.15) 0.69 1.08 (0.79-1.48) 0.63
3 187317193 rs9816226 ETV5 T A 0.956 1.00 (0.83-1.21) 0.96 1.11 (0.77-1.60) 0.56
4 44877284 rs10938397 GNPDA2 G A 0.988 1.11 (0.96-1.28) 0.17 1.09 (0.83-1.42) 0.53
4 103407732 rs13107325 SLC39A8 T C 0.997 1.09 (0.83-1.43) 0.55 0.94 (0.57-1.55) 0.79
5 75050998 rs2112347 FLJ35779/HMGCR T G 0.995 1.21 (1.04-1.40) 0.012 0.92 (0.70-1.21) 0.55
5 124360002 rs4836133 ZNF608 A C 0.943 1.07 (0.92-1.23) 0.39 1.11 (0.85 -1.45) 0.45
6 34410847 rs206936 HMGA1 G A 0.988 1.01 (0.85-1.21) 0.89 0.97 (0.69-1.35) 0.85
6 50911009 rs987237 TFAP2B G A 0.999 1.01 (0.84-1.21) 0.93 1.28 (0.93-1.76) 0.14
9 28404339 rs10968576 LRRN6C G A 0.999 1.06 (0.91-1.23) 0.48 0.89 (0.67-1.18) 0.40
11 8561169 rs4929949 RPL27A C T 0.967 0.93 (0.80-1.07) 0.33 1.06 (0.81-1.38) 0.69
11 27682562 rs10767664 BDNF A T 0.997 1.04 (0.87-1.25) 0.64 1.39 (0.98-1.97) 0.056
11 47607569 rs3817334 MTCH2 T C 0.998 1.01 (0.87-1.16) 0.90 1.05 (0.81-1.36) 0.72
12 48533735 rs7138803 FAIM2 A G 0.998 1.00 (0.86-1.15) 0.97 0.98 (0.75-1.29) 0.90
13 26918180 rs4771122 MTIF3 G A 0.931 0.91 (0.77-1.09) 0.30 1.03 (0.75-1.42) 0.84
14 29584863 rs11847697 PRKD1 T C 0.969 0.93 (0.65-1.33) 0.69 0.72 (0.36-1.44) 0.33
14 79006717 rs10150332 NRXN3 C T 0.996 0.89 (0.74-1.06) 0.19 0.70 (0.49-1.01) 0.047
15 65873892 rs2241423 MAP2K5 G A 0.999 1.05 (0.88-1.25) 0.59 0.86 (0.64-1.17) 0.34
16 19841101 rs12444979 GPRC5B C T 0.998 1.06 (0.86-1.30) 0.59 1.44 (0.94-2.21) 0.083
16 28793160 rs7359397 SH2B1 T C 0.999 0.97 (0.84-1.11) 0.63 0.97 (0.74-1.26) 0.81
16 52361075 rs1558902 FTO A T 0.997 1.30 (1.13-1.49) 3.3 3 1024 1.23 (0.92-1.64) 0.51
18 55990749 rs571312 MC4R A C 0.999 1.04 (0.88-1.23) 0.62 1.23 (0.92-1.64) 0.17
19 39001372 rs29941 KCTD15 G A 0.999 0.96 (0.83-1.12) 0.61 0.98 (0.75--1.29) 0.90
19 50894012 rs2287019 QPCTL/GIPR C T 0.999 1.05 (0.88-1.26) 0.58 0.81 (0.59-1.12) 0.21
19 52260843 rs3810291 TMEM160 A G 0.765 1.10 (0.93-1.31) 0.27 0.84 (0.62-1.14) 0.26
aBMI increaser allele.
bOne tailed binomial sign test indicated that the direction of allelic association with binge eating did not occur significantly more often in the same direction as the known
BMI associations (females P5 0.11; males P50.298).
Bold font indicates statistically significant results (P 0.05).
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overweight/obesity via higher palatable food and energy intake and
decreased satiety; or that binge eating might be a mediator on the
pathway between genotype and increased BMI/obesity.
Our findings of: (a) an association between an FTO locus SNP and
binge eating, that showed little reduction in strength after condition-
ing on BMI, (b) the lack of association with other BMI-increasing
SNPS, and (c) an association between the allelic risk score and
binge eating when FTO was included that attenuated markedly after
excluding FTO from the allelic risk score suggests that the effect of
FTO on binge eating is not mediated by BMI. Therefore our
findings suggest either pleiotropic effects of variants in or near the
FTO locus, or that binge eating might be on the causal pathway
between genetic variants and obesity. We have shown in two large
population-based cohorts (including the one under study) that BED
significantly increases the odds of overweight/obesity even when
taking into account baseline weight (3) (Micali et al., submitted).
Recent findings have highlighted differences in prefrontal cortex
activation in the processing of food stimuli associated with FTO
polymorphisms, with lower activity (hence lower inhibitory control
of eating) in this brain region post-prandially in subjects carrying
TABLE 4 Associations between frequency of binge eating in adolescence and genetic variants reliably related to BMI
Chrom Position SNP Putative gene
Effect
alleleb
Other
allele
Minimally adjusted
modela, age 14
(N54,359)
Minimally adjusted
modela, age 16
(N =3,663)
OR (95% CI)b P value OR (95% CI)b P value
1 72585028 rs2815752 NEGR1 A G 0.98 (0.81-1.19) 0.87 1.10 (0.95-1.28) 0.19
1 74764232 rs1514175 TNNI3K A G 1.00 (0.83-1.20) 0.98 1.17 (1.01-1.36) 0.03
1 96717385 rs1555543 PTBP2 C A 0.95 (0.79-1.15) 0.62 1.06 (0.92-1.24) 0.38
1 176156103 rs543874 SEC16B G A 0.97 (0.78-1.22) 0.84 1.03 (0.87-1.23) 0.70
2 612827 rs2867125 TMEM18 C T 1.12 (0.87-1.44) 0.38 1.14 (0.93-1.39) 0.19
2 25011512 rs713586 RBJ/ADCY3/POMC C T 1.11 (0.92-1.33) 0.26 0.94 (0.81- 1.09) 0.41
2 59156381 rs887912 FANCL T C 0.96 (0.78-1.17) 0.70 0.86 (0.73-1.01) 0.07
2 142676401 rs2890652 LRP1B C T 0.98 (0.77-1.25) 0.90 1.00 (0.83-1.21) 0.97
3 85966840 rs13078807 CADM2 G A 1.13 (0.91-1.41) 0.26 0.93 (0.77-1.23) 0.46
3 187317193 rs9816226 ETV5 T A 0.98 (0.77-1.25) 0.89 0.94 (0.78-1.15) 0.60
4 44877284 rs10938397 GNPDA2 G A 1.18 (0.98-1.42) 0.08 1.04 (0.89-1.20) 0.62
4 103407732 rs13107325 SLC39A8 T C 0.97 (0.68-1.39) 0.88 1.11 (0.83-1.48) 0.46
5 75050998 rs2112347 FLJ35779/HMGCR T G 1.11 (0.91-1.35) 0.29 1.09 (0.93-1.27) 0.27
5 124360002 rs4836133 ZNF608 A C 1.19 (0.98-1.44) 0.07 1.04 (0.89-1.20) 0.62
6 34410847 rs206936 HMGA1 G A 1.16 (0.93-1.45) 0.19 0.99 (0.82-1.19) 0.94
6 50911009 rs987237 TFAP2B G A 1.08 (0.85-1.37) 0.51 0.94 (0.78-1.15) 0.56
9 28404339 rs10968576 LRRN6C G A 0.89 (0.73-1.09) 0.26 1.07 (0.92-1.26) 0.34
11 8561169 rs4929949 RPL27A C T 0.88 (0.73-1.06) 0.17 0.97 (0.84-1.13) 0.74
11 27682562 rs10767664 BDNF A T 1.22 (0.96-1.55) 0.10 1.09 (0.90-1.31) 0.36
11 47607569 rs3817334 MTCH2 T C 1.21 (1.01-1.46) 0.03 0.95 (0.82-1.11) 0.55
12 48533735 rs7138803 FAIM2 A G 0.93 (0.77-1.12) 0.44 1.08 (0.93-1.26) 0.30
13 26918180 rs4771122 MTIF3 G A 1.02 (0.82-1.27) 0.85 0.99 (0.82-1.18) 0.88
14 29584863 rs11847697 PRKD1 T C 0.78 (0.48-1.27) 0.32 0.90 (0.63-1.29) 0.59
14 79006717 rs10150332 NRXN3 C T 0.86 (0.68-1.09) 0.21 0.92 (0.77-1.11) 0.41
15 65873892 rs2241423 MAP2K5 G A 0.94 (0.75-1.16) 0.55 0.96 (0.81-1.15) 0.67
16 19841101 rs12444979 GPRC5B C T 1.20 (0.90-1.59) 0.21 1.07 (0.86-1.33) 0.53
16 28793160 rs7359397 SH2B1 T C 1.00 (0.83-1.20) 0.99 0.93 (0.81-1.09) 0.40
16 52361075 rs1558902 FTO A T 1.21 (1.01-1.46) 0.04 1.28 (1.10-1.48) 1.0 3 1023
18 55990749 rs571312 MC4R A C 1.06 (0.86-1.31) 0.58 1.05 (0.88-1.25) 0.57
19 39001372 rs29941 KCTD15 G A 0.97 (0.79-1.18) 0.73 0.91 (0.78-1.06) 0.26
19 50894012 rs2287019 QPCTL/GIPR C T 1.10 (0.86-1.39) 0.44 0.97 (0.81-1.16) 0.76
19 52260843 rs3810291 TMEM160 A G 0.94 (0.76-1.17) 0.59 1.03 (0.87-1.24) 0.68
aFor age and BMI.
bOne tailed binomial sign test indicated that the direction of allelic association with binge eating did not occur significantly more often in the same direction as the known
BMI associations (age 14 P5 0.43; age 16 P5 0.43).
Bold font indicates statistically significant results (P 0.05).
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the risk allele (31). Evidence also suggests that FTO rs9939609 AA
carriers have a different brain response to food and ghrelin expres-
sion compared to TT carriers (32).
Thus, evidence from behavioral genetics and neuroimaging studies
supports our findings that genetic variation at the FTO locus might
confer risk of binge eating. In our study, the strongest associations
between the FTO polymorphism and binge eating were most evident
in girls; although this might be due to a lower prevalence of binge
eating in boys and hence lower power to detect differences, or a
true differential gender effect (although the formal test for interac-
tion was negative).
In gender-stratified analyses some polymorphisms were nominally
associated with binge eating: (e.g., a polymorphism in FLJ35779/
HMGCR in girls, and a polymorphism in NEGR1 with binge eating
in boys). A variant at MTCH2 was associated with frequency of
binge eating at age 14 years, and a polymorphism in TNNI3K with
frequency of binge eating at age 16 years. These findings might
reflect type I error given the large number of statistical comparisons
performed in this paper, and the rather weak P values. Future stud-
ies should aim to replicate these findings. FLJ35779/HMGCR has
not, to our knowledge, been previously implicated in appetite regu-
lation. In contrast the TNNI3K and MTCH2 obesity risk-conferring
SNPs have both been shown to be positively associated with emo-
tional eating and uncontrolled eating (17). Emotional eating and
uncontrolled eating are traits strongly associated with binge eating,
and confer risk for binge eating.
Amongst the SNPs studied we did not find an association between
binge eating and variants within MC4R or RBJ/ADCY3/POMC,
despite evidence from previous studies that mutations in the melano-
cortin 4 receptor (MC4R) and the Pro Opio Melanocortin (POMC)
genes might be implicated in appetite control (33,34). Similarly,
polymorphisms in the BDNF gene have been shown to be associated
with ED phenotypes (35) but were not strongly associated with
binge eating in this study. This might be due to low power to detect
associations in our study, or to the selection of more severe pheno-
types in previous studies (mostly reliant on clinical populations).
Strengths of our study include a relatively large sample size in com-
parison to previous studies on genetic risk for binge eating, an
investigation of binge eating as a dichotomous outcome and of as an
ordinal outcome (i.e., frequency of binge eating), and a candidate
gene approach based on 32 SNPs robustly associated with BMI. We
also investigated a possible relationship between a weighted allelic
risk score and binge eating. Limitations include the fact that data on
binge eating were collected using self-report, however our questions
were validated in a population-based sample and showed high reli-
ability and validity (36). Secondly, this sample mostly includes sub-
jects of European ancestry, which might limit generalizability of
findings. Thirdly, despite being one of the larger genetic studies of
binge eating, our study has low statistical power in some analyses,
partially due to the lower prevalence of binge eating amongst boys,
which might have resulted in false negatives in the associations
reported. Our study has limited power to detect genetic variants
associated with binge eating in adolescence. This is because of our
limited sample size and the fact that genetic variants that influence
complex traits like binge eating are likely to exhibit relatively small
effects. For example in the case of rs1558902 (FTO) which has a
risk allele frequency of 0.4, assuming 586 cases and 4331 controls
(a prevalence of 13%), a heterozygote relative risk of 1.1, a multi-
plicative disease model (on the risk scale), we only have 40%
power to detect an association at a5 0.05 using an allelic test of
association. This calculation illustrates that our study has low to
moderate power to detect association at individual variants if the
effect size of these variants is small (as is likely to be the case).
However, assuming that one or more variants jointly contribute to
binge eating, combining the variants into an allelic score should
increase our power to detect association. Whilst an allelic score
comprised of BMI associated variants did show some association
with binge eating, our results suggest that most of this association
was due to the FTO variant, rather than the other BMI related SNPs.
We were unable to carry out a replication of our findings in an inde-
pendent sample within the current study; therefore our findings need
replication. However, it should be noted that Tanofsky-Kraff et al.
(16) observed an association between a SNP at the FTO locus and
loss-of-control eating; thus, our finding could be considered a
replication.
Conclusion
This study suggests a positive association between a polymorphism
in the FTO gene and adolescent binge eating, particularly in girls.
Taken together with previous research, it appears that variants
within or near the FTO locus are associated with a preference for
energy-dense foods, greater food intake, less sensitivity to satiety
cues, and loss-of-control eating episodes, all of which characterize
binge eating. A recent GWAS of 339,224 individuals (37) has iden-
tified 97 loci associated with BMI; future studies should therefore
test the effect of a weighted allelic score incorporating all 97 loci on
binge eating. In the absence of a GWAS of binge eating or BED,
future larger studies should also aim to confirm our findings and
examine potential risk mechanisms or shared pathways between obe-
sity and binge eating. A GWAS of binge eating or BED is likely to
be achievable by pooling available samples across the world.O
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